Analyst consensus rating
Exagen Analyst Rating: Strong Buy
Direct answer
Exagen's consensus rating is Strong Buy.
7 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $9.43.
Forecast evidence checked November 14, 2026.
Get free Exagen email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.13
- Average price target
- $9.43
- High price target
- $12.00
- Low price target
- $8.00
- Low target gap
- +93.7%
- Target upside
- +128.3%
- High target gap
- +190.6%
- Target range width
- 96.9%
- Consensus rating
- Strong Buy
- Analysts
- 7
- Evidence date
- November 14, 2026
- Valid through
- November 21, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Exagen?
Exagen has a verified Strong Buy consensus. The same dataset has an average price target of $9.43.
How far are Exagen's low and high targets from the recorded price?
The low target implies +93.7%, while the high target implies +190.6%.
How many analysts are included in Exagen's consensus?
The verified consensus includes 7 analysts.
How is Exagen's target upside or downside calculated?
The average target of $9.43 is divided by the recorded price of $4.13, then one is subtracted to produce +128.3%. This does not guarantee a future return.
When was Exagen's analyst forecast verified?
The data was verified on 2026-11-14. The dataset is valid through 2026-11-21.